Repare Therapeutics - Stock Price History | RPTX

Historical daily share price chart and data for Repare Therapeutics since 2021 adjusted for splits. The latest closing stock price for Repare Therapeutics as of September 27, 2021 is 27.28.
  • The all-time high Repare Therapeutics stock closing price was 44.46 on January 07, 2021.
  • The Repare Therapeutics 52-week high stock price is 46.44, which is 70.2% above the current share price.
  • The Repare Therapeutics 52-week low stock price is 21.76, which is 20.2% below the current share price.
  • The average Repare Therapeutics stock price for the last 52 weeks is 32.27.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Repare Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 28.4106 30.8000 39.5000 21.5500 34.3000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.013B $0.000B
Repare Therapeutics Inc. is an oncology company. It utilizes genome-wide, CRISPR-enabled SNIPRx(R) platform to discover and develop targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company's product pipeline includes RP-3500, which is in clinical stage. Repare Therapeutics Inc. is based in St-Laurent, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29